Mammary epithelial cells were isolated from mid-pregnant BALB/c mice,
grown in primary culture within collagen gels, and maintained with ser
um-free medium containing 10 ng/ml epidermal growth factor (EGF) as th
e mitogen. Supplementation of culture medium with the saturated fatty
acid, Na-stearate (18:0), significantly attenuated, whereas treatment
with the unsaturated fatty acid, Na-arachidonate (20:4), significantly
enhanced mammary epithelial cell proliferation, as compared to untrea
ted controls. Treatment with various doses of either 18:0 or 20:4 was
also found to result in a direct dose-dependent enrichment of mammary
epithelial cell membrane fatty acid composition and a concurrent decre
ase in the relative levels of other membrane fatty acids, as determine
d by gas chromatography. Administration of the prostaglandin synthesis
inhibitor, indomethacin, significantly inhibited EGF-induced cell gro
wth in all treatment groups, but did not alter the relative inhibitory
(18:0) or stimulatory (20:4) effects of fatty acid treatment. EGF-ind
uced PRC translocation into the membrane fraction of mammary epithelia
l cells was enhanced in 20:4 and attenuated in 18:0 treatment groups,
as compared to controls. Western blot analysis of phospholipid-depende
nt protein kinase C isoenzymes showed that PKC, was the predominant is
oenzyme present in mouse mammary epithelial cells grown in primary cul
ture, and the molecular weight of this PKC isoenzyme was determined to
be 85 kDa. These results suggest that supplementation of culture medi
a with specific fatty acids is associated with significant alterations
in mammary epithelial cell membrane fatty acid composition, PKC activ
ation, and mitogenic responsiveness. Since EGF can induce both PRC act
ivation and cell proliferation, and because PKC activation requires me
mbrane-derived phospholipids and diacylglycerol, these data suggest th
at specific fatty acid modulation of mammary epithelial cell mitogenes
is is mediated through alterations in PRC, activation. (C) 1994 Academ
ic Press, Inc.